Skip to main content

Hematologic Malignancies Specialists

3,899 verified specialists treating hematologic malignancies from across the United States are listed on this page. Top affiliations among the highest-ranked specialists include Dana-Farber Cancer Institute, Penn Presbyterian Medical Center, and Abramson Cancer Center, University of Pennsylvania. Drill into a state below to find specialists nearer to you, or compare individual profiles for credentials, focus areas, and clinical depth.

Daniel Deangelo

Daniel Deangelo, M.D.,PH.D.

Chief, Division of Leukemia Institute Physician; Professor of Medicine, Harvard Medical School

Hematology

Boston, MA30+ years
Hematology & Oncology
Edward Stadtmauer

Edward Stadtmauer, MD

Director, Hematologic Malignancies Clinical/Translational Research, Division of Hematology/Oncology; Roseman, Tarte, Harrow, and Shaffer Families' President's Distinguished Professor

Hematology

Philadelphia, PA30+ years
Hematology & OncologyMedical Oncology
Eric Jacobsen

Eric Jacobsen, MD

Associate Professor of Medicine, Harvard Medical School; Clinical Director, Adult Lymphoma Program; Director, Histiocyte Disorders Center

Hematology

Boston, MA20+ years
Hematology & Oncology
Paul Richardson

Paul Richardson, MD

Director in 2001, and led the study and development of several pivotal novel drugs including thalidomide, lenalidomide, bortezomib, pomalidomide, panobinostat; Professor of Medicine at Harvard Medical School in 2012, and then became Clinical Program Leader and Director of Clinical Research in 2014.

Hematology

Milford, MA30+ years
Hematology & Oncology
James Foran

James Foran, MD

Hematology

Jacksonville, FL30+ years
Hematology & Oncology
Jaroslaw Maciejewski

Jaroslaw Maciejewski, MD

Professor of Medicine

Hematology

Cleveland, OH30+ years
Malignant Hematology
Morie Gertz

Morie Gertz, M.D.

Roland Seidler Jr. Professor of the Art of Medicine; Chair Emeritus, Department of Internal Medicine

Hematology

Rochester, MN30+ years
Malignant Hematology
Thomas Habermann

Thomas Habermann, M.D.

Professor of Medicine, Mayo Clinic

Hematology

Rochester, MN30+ years
Malignant HematologyLymphoma
Leo Gordon

Leo Gordon, MD

Professor, Feinberg School of Medicine

Hematology

Chicago, IL30+ years
Hematology & Oncology
John Glaspy

John Glaspy, MD

Professor of Medicine

Hematology

Torrance, CA30+ years
Hematology & Oncology
Stephen Schuster

Stephen Schuster, MD

Robert and Margarita Louis-Dreyfus Professor in Chronic Lymphocytic Leukemia and Lymphoma Clinical Care and Research; Director, Lymphoma Translational Research, Abramson Cancer Center; Associate Professor, Medicine

Hematology

Philadelphia, PA30+ years
Hematology & Oncology
Jane Winter

Jane Winter, MD

Professor, Feinberg School of Medicine, Division of Hematology Oncology

Hematology

Lake Forest, IL30+ years
Hematology & Oncology
Nancy Lin

Nancy Lin, MD

Professor of Medicine at Harvard Medical School, Dr. Lin’s research focuses on developing more effective therapies for patients with metastatic breast ca

Hematology

Boston, MA20+ years
Hematology & Oncology
Ralph Boccia

Ralph Boccia, M.D.

Clinical Associate Professor of Medicine, Georgetown University; Chief Medical Officer, International Oncology Network

Hematology

Washington, DC30+ years
Hematology & OncologyMedical Oncology
George Fisher

George Fisher, MD

Associate Professor, Medicine, Stanford University School of Medicine

Hematology

Stanford, CA30+ years
Hematology & Oncology
David Henry

David Henry, MD

Vice Chair, Department of Medicine; Clinical Professor of Medicine (Hematology-Oncology)

Hematology

Radnor, PA30+ years
Hematology & Oncology
Paolo Caimi

Paolo Caimi, M.D.

Associate Professor of Medicine, Cleveland Clinic Lerner College of Medicine; Associate Director for Cell Therapy, Cleveland Clinic Taussig Cancer Center

Hematology

Cleveland, OH20+ years
Hematology & Oncology
Sunita Nasta

Sunita Nasta, MD

Section Chief, Lymphoma, Hematology-Oncology; Professor of Clinical Medicine (Hematology-Oncology); Chair, Clinical Trials Review Monitoring Committee; Committee Chair, Penn Institutional Review Board

Hematology

Philadelphia, PA30+ years
Hematology & OncologyMedical Oncology
Corey Langer

Corey Langer, MD

Professor of Medicine (Hematology-Oncology)

Hematology

Philadelphia, PA30+ years
Hematology & Oncology
Thomas Kupper

Thomas Kupper, MD

Thomas B. Fitzpatrick Professor of Dermatology; Chair, Department of Dermatology, Brigham and Women's Hospital

Hematology

Boston, MA30+ years
Hematology & Oncology

Hematologic Malignancies specialists by state

Find hematologic malignancies specialists in your state.

Frequently Asked Questions

How is this national list of hematologic malignancies specialists built?
This page includes physicians in Convene Health's public directory whose profile lists Hematologic Malignancies as a clinical focus area, ranked by composite score (research output, peer recognition, frequency of care, and outcomes signals). Each profile is sourced from the NPI registry, peer-reviewed publication data, board certification records, and the physician's own bio where available.
What should I look for when choosing a hematologic malignancies specialist?
Start with clinical fit — the right specialist for hematologic malignancies depends on the specific subtype and severity of your condition. Compare credentials, hospital affiliations, years of experience, peer-reviewed publications, and how the profile describes their approach. Many top specialists are concentrated at academic medical centers; if you have flexibility on location, the top of this list is a strong starting set.
Are these hematologic malignancies specialists accepting new patients?
Profile detail on availability and accepted insurance varies. Open a specific provider profile to see what they've published about new-patient access, insurance accepted, and typical wait times. Coverage details can change — confirm directly with the practice before your visit.
What is Hematologic Malignancies?
Hematologic Malignancies is a clinical focus area covered by the specialists listed here. Each provider profile describes their training, sub-specialties, and the conditions they regularly treat — open a profile for the most authoritative description of how that specific physician approaches hematologic malignancies care.